phase readout
saveNCT06846606: Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
ACTIVE_NOT_RECRUITINGupdated 2h ago
community read0 votes
Sponsor: Auron Therapeutics, Inc.. Phase: PHASE1. Conditions: Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapsed/Refractory AML, Relapsed Myelodysplastic Syndromes, Refractory Myelodysplastic Syndromes, Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
view source ↗
comments(0)
5-min edit window · permanent after that